[1] | Pan DJ. Hippo signaling in organ size control. Genes Dev, 2007, 21(8): 886-897. | [2] | Zhao B, Lei QY, Guan KL. The Hippo-YAP pathway: new connections between regulation of organ size and cancer. Curr Opin Cell Biol, 2008, 20(6): 638-646. | [3] | Zhao B, Li L, Lei QY, Guan KL. The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev, 2010, 24(9): 862-874. | [4] | Zhao B, Tumaneng K, Guan KL. The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal. Nat Cell Biol, 2011, 13(8): 877-883. | [5] | Saucedo LJ, Edgar BA. Filling out the Hippo pathway. Nat Rev Mol Cell Biol, 2007, 8(8): 613-621. | [6] | Zhang L, Yue T, Jiang J. Hippo signaling pathway and organ size control. Fly, 2009, 3(1): 68-73. | [7] | Harvey KF, Pfleger CM, Hariharan IK. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell, 2003, 114(4): 457-467. | [8] | Jia JH, Zhang WS, Wang B, Trinko R, Jiang J. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev, 2003, 17(20): 2514-2519. | [9] | Pantalacci S, Tapon N, Léopold P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol, 2003, 5(10): 921-927. | [10] | Udan RS, Kango-Singh M, Nolo R, Tao CY, Halder G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol, 2003, 5(10): 914-920. | [11] | Lai ZC, Wei XM, Shimizu T, Ramos E, Rohrbaugh M, Nikolaidis N, Ho LL, Li Y. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell, 2005, 120(5): 675-685. | [12] | Justice RW, Zilian O, Woods DF, Noll M, Bryant PJ. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev, 1995, 9(5): 534-546. | [13] | Xu T, Wang W, Zhang S, Stewart RA, Yu W. Identifying tumor suppressors in genetic mosaics: the Drosophila Lats gene encodes a putative protein kinase. Development, 1995, 121(4): 1053-1063. | [14] | Kango-Singh M, Nolo R, Tao CY, Verstreken P, Hiesinger PR, Bellen HJ, Halder G. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development, 2002, 129(24): 5719-5730. | [15] | Tapon N, Harvey KF, Bell DW, Wahrer DCR, Schiripo TA, Haber DA, Hariharan IK. Salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell, 2002, 110(4): 467-478. |
[1] |
孔维泽, 柳艺石, 高晓冬, 藤田盛久. 数据驱动的人体正常和癌症组织中糖基磷脂酰肌醇锚定蛋白(GPI-AP)相关基因表达谱的综合分析[J]. 遗传, 2023, 45(8): 669-683. |
[2] |
漆思晗, 王棨临, 张俊有, 刘倩, 李春燕. 增强子调控癌症发生发展的机制研究[J]. 遗传, 2022, 44(4): 275-288. |
[3] |
雷常贵, 贾学渊, 孙文靖. 基于癌症基因组图谱计划多组学数据构建胶质母细胞瘤六基因预后模型[J]. 遗传, 2021, 43(7): 665-679. |
[4] |
于雅洁, 邱峰, 张新安. TSR1突变导致先天性白内障及其在晶状体中的表达[J]. 遗传, 2020, 42(2): 161-171. |
[5] |
曹俊霞, 王友亮, 王征旭. 精准调控CRISPR/Cas9基因编辑技术研究进展[J]. 遗传, 2020, 42(12): 1168-1177. |
[6] |
吴玉娴, 王琰. PCSK9降解低密度脂蛋白受体分子机制研究进展[J]. 遗传, 2020, 42(10): 965-978. |
[7] |
张競文,续倩,李国亮. 癌症发生发展中的表观遗传学研究[J]. 遗传, 2019, 41(7): 567-581. |
[8] |
欧浩,李国玲,王豪强,黄广燕,蔡更元,李紫聪,吴珍芳,张献伟. MEK抑制剂PD0325901显著提高猪胎儿成纤维细胞ssODN介导的HDR效率[J]. 遗传, 2019, 41(4): 327-336. |
[9] |
吴志强, 米泽云. 超级增强子在肿瘤研究中的进展[J]. 遗传, 2019, 41(1): 41-51. |
[10] |
孙书国, 吴世安, 张雷. Hippo信号通路在果蝇遗传学研究中的发现与扩展[J]. 遗传, 2017, 39(7): 537-545. |
[11] |
吉新彦, 钟国轩, 赵斌. 哺乳动物Hippo信号通路分子机制研究进展[J]. 遗传, 2017, 39(7): 546-567. |
[12] |
张平平,佟鑫,张天乐,黎子琛,龚清秋. 植物Hippo信号通路研究进展[J]. 遗传, 2017, 39(7): 568-575. |
[13] |
顾远, 张雷, 余发星. Hippo信号通路在肠道稳态、再生及癌变过程中的作用及机制[J]. 遗传, 2017, 39(7): 588-596. |
[14] |
付思玲,赵婉滢,张雯婧,宋海,季红斌,汤楠. Hippo信号通路在肺发育、再生和疾病中的功能[J]. 遗传, 2017, 39(7): 597-606. |
[15] |
姚传波, 周鑫, 陈策实, 雷群英. Hippo信号通路在乳腺癌中的调控机制及作用[J]. 遗传, 2017, 39(7): 617-629. |
|